# External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients

> **NCT06224244** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Regina Elena Cancer Institute** · enrollment: 180 (actual)

## Conditions studied

- Breast Neoplasms
- Breast Cancer

## Interventions

- **RADIATION:** Ten-fraction hypofractionated breast radiotherapy with 40 Gy simultaneous integrated bed boost
- **RADIATION:** Ten-fraction hypofractionated breast radiotherapy with 43 Gy simultaneous integrated bed boost

## Key facts

- **NCT ID:** NCT06224244
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-01
- **Primary completion:** 2025-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06224244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06224244, "External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06224244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*